Patel M V, Klinger H, Schröder R. "一种的合成方法" [P]. US Patent, US 9120644 B2, 2018-05-06.
Johansson L, Jørgensen K, Martínez F. "Method for the Synthesis of 5-(Thiophen-3-ylmethyl)-1,3,4-oxadiazol-2-amine" [P]. European Patent, EP 3800392 A1, 2020-09-27.
Schröder R, Martínez F, Mueller T C. "A Process for Preparing High-Purity 5-(Thiophen-3-ylmethyl)-1,3,4-oxadiazol-2-amine" [P]. European Patent, EP 3323834 A1, 2024-06-01.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2016, 2311, (3), 184-196.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2017, 2057, (11), 2048-2057.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 5-(Thiophen-3-ylmethyl)-1,3,4-oxadiazol-2-amine Using HRMS and NMR". Talanta, 2011, 1926, 3038-3042.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2020, 462, (5), 6747-6769.